Technology
Health
Biotechnology

Opiant

$13.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-1.75%) Today
+$0.13 (1.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Opiant and other stocks, options, ETFs, and crypto commission-free!

About OPNT

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Read More Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

Employees
16
Headquarters
Santa Monica, California
Founded
2005
Market Cap
51.42M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
12.44K
High Today
$13.25
Low Today
$12.90
Open Price
$13.24
Volume
40.05K
52 Week High
$29.55
52 Week Low
$9.98

Collections

Technology
Health
Biotechnology
Pharmaceutical
Medical
2016 IPO
US
North America

OPNT Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.